Literature DB >> 16300457

Epidemiology of hyperuricemia and gout.

Andrew J Luk, Peter A Simkin.   

Abstract

Gout is an increasingly common medical problem. The traditional risk factors of male sex and high red meat or alcohol consumption have been joined by a wave of newer risk factors, such as increased longevity, the metabolic syndrome (hypertension, diabetes, dyslipidemia, truncal obesity, increased cardiovascular disease risk), use of diuretics, low-dose aspirin, or cyclosporine, and end-stage renal disease. Atypical presentations of gout in the elderly can mimic osteoarthritis and rheumatoid arthritis. There is a resurgence of interest in hyperuricemia as an independent and potentially modifiable cardiovascular risk factor. The pharmacologic management of gout in general practice suffers from a number of quality-control issues. This article reviews these and other new epidemiologic data on this ancient disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300457

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  47 in total

1.  Association between gout and polymorphisms in GCKR in male Han Chinese.

Authors:  Jing Wang; Shiguo Liu; Binbin Wang; Zhimin Miao; Lin Han; Nan Chu; Kun Zhang; Dongmei Meng; Changgui Li; Xu Ma
Journal:  Hum Genet       Date:  2012-03-07       Impact factor: 4.132

2.  Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population.

Authors:  Binbin Wang; Zhimin Miao; Shiguo Liu; Jing Wang; Shiyi Zhou; Lin Han; Dongmei Meng; Yunlong Wang; Changgui Li; Xu Ma
Journal:  Hum Genet       Date:  2009-11-17       Impact factor: 4.132

Review 3.  Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.

Authors:  José M A Wijnands; Wolfgang Viechtbauer; Kristof Thevissen; Ilja C W Arts; Pieter C Dagnelie; Coen D A Stehouwer; Sjef van der Linden; Annelies Boonen
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

4.  Spondyloarthritis: a gouty display.

Authors:  Preetam Gongidi; Shawn Gough-Fibkins
Journal:  J Radiol Case Rep       Date:  2010-05-01

Review 5.  Management of gout in general practice--a systematic review.

Authors:  Andrew Jeyaruban; Sarah Larkins; Muriel Soden
Journal:  Clin Rheumatol       Date:  2014-09-17       Impact factor: 2.980

6.  Adherence and persistence to urate-lowering therapies in the Irish setting.

Authors:  Bernie McGowan; Kath Bennett; Carmel Silke; Bryan Whelan
Journal:  Clin Rheumatol       Date:  2014-11-20       Impact factor: 2.980

7.  The CC chemokine ligand 2 (CCL2) polymorphism -2518A/G is associated with gout in the Chinese Han male population.

Authors:  Ruixia Sun; Keke Zhang; Xiaokun Zhang; Lingling Cui; Can Wang; Qingsheng Mi; Shiguo Liu; Changgui Li
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

8.  A meta-analysis of alcohol consumption and the risk of gout.

Authors:  Meiyun Wang; Xiubo Jiang; Wenlong Wu; Dongfeng Zhang
Journal:  Clin Rheumatol       Date:  2013-07-24       Impact factor: 2.980

9.  Lack of association between dietary fructose and hyperuricemia risk in adults.

Authors:  Sam Z Sun; Brent D Flickinger; Patricia S Williamson-Hughes; Mark W Empie
Journal:  Nutr Metab (Lond)       Date:  2010-03-01       Impact factor: 4.169

10.  Hyperuricemia and its related factors in an urban population, Izmir, Turkey.

Authors:  Ismail Sari; Servet Akar; Betul Pakoz; Ali Riza Sisman; Oguz Gurler; Merih Birlik; Fatos Onen; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2008-12-02       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.